Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer
about
Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedureUnderstanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets.MicroRNA profiling identifies miR-7-5p and miR-26b-5p as differentially expressed in hypertensive patients with left ventricular hypertrophyRole of Non-Coding RNAs in the Etiology of Bladder Cancer.Expression of miR-149-3p inhibits proliferation, migration, and invasion of bladder cancer by targeting S100A4.Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated with Clopidogrel-Induced Hepatotoxicity in HepG2 Cells.Involvement of aberrantly expressed microRNAs in the pathogenesis of head and neck squamous cell carcinoma.Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen.Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.Molecular pathogenesis of pancreatic ductal adenocarcinoma: impact of passenger strand of pre-miR-148a on gene regulation.SuperQuant-assisted comparative proteome analysis of glioblastoma subpopulations allows for identification of potential novel therapeutic targets and cell markers.Bromodomain protein BRD4 inhibitor JQ1 regulates potential prognostic molecules in advanced renal cell carcinoma.miR-26a suppresses osteosarcoma migration and invasion by directly targeting HMGA1.Roles of PLODs in Collagen Synthesis and Cancer Progression.Potential biomarkers and therapeutic targets in cervical cancer: Insights from the meta-analysis of transcriptomics data within network biomedicine perspective
P2860
Q33689126-65191A7D-A654-4410-B996-7D866B15068AQ39432577-594502CD-F0E9-48B5-B575-A47423E4D778Q42664564-7B7EF1E0-6E42-4336-8536-CF17AA98B4B8Q46236214-9D04E029-1C63-4344-A54D-19DC200E8B42Q47142687-26AFF5D4-461F-4E65-9F80-3B28EBF71795Q47335450-2889275C-3275-445B-9FED-9C93B0B4E75BQ47912856-94073062-39E1-4680-A9E0-BFDE737E9396Q49834126-4A376772-7F80-4881-83F9-6DE09E45114FQ50784672-A20581CF-B90C-4E84-9AAC-F8EA4D739769Q52585697-5AB4E12E-993D-457C-8BAF-EDEF1B470118Q52672948-AA557022-E7D3-4E19-9527-072A8D85A8E3Q54977082-13F7081B-6FA9-40E7-9F9A-286ADB81DC29Q55315505-51F568EC-308B-4973-AA50-555AE49A79D4Q55636893-D09E1792-2724-4520-9BAD-384A2DA02F32Q56889614-626DB274-DD16-4F05-BC12-380246B26748
P2860
Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Tumour-suppressive miRNA-26a-5 ...... lating PLOD2 in bladder cancer
@en
type
label
Tumour-suppressive miRNA-26a-5 ...... lating PLOD2 in bladder cancer
@en
prefLabel
Tumour-suppressive miRNA-26a-5 ...... lating PLOD2 in bladder cancer
@en
P2093
P2860
P356
P1476
Tumour-suppressive miRNA-26a-5 ...... lating PLOD2 in bladder cancer
@en
P2093
K Miyamoto
M Nakagawa
M Yonemori
R Matsushita
P2860
P2888
P304
P356
10.1038/BJC.2016.179
P407
P577
2016-06-16T00:00:00Z
P6179
1011899769